PT790237E - BICYCLOLATING COMPOUNDS ITS USES AND INTERMEDIARIES IN ITS PRODUCTION - Google Patents

BICYCLOLATING COMPOUNDS ITS USES AND INTERMEDIARIES IN ITS PRODUCTION

Info

Publication number
PT790237E
PT790237E PT96916350T PT96916350T PT790237E PT 790237 E PT790237 E PT 790237E PT 96916350 T PT96916350 T PT 96916350T PT 96916350 T PT96916350 T PT 96916350T PT 790237 E PT790237 E PT 790237E
Authority
PT
Portugal
Prior art keywords
effect
bicyclolating
intermediaries
compounds
production
Prior art date
Application number
PT96916350T
Other languages
Portuguese (pt)
Inventor
Kazuo Ogawa
Ichiro Yamawaki
Manabu Kaneda
Takashi Arima
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of PT790237E publication Critical patent/PT790237E/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bicyclolactam compounds represented by general formula (1) are useful as the active ingredient of medicines having an excellent anxiolytic effect and a high safety with little side effects such as a hypnotic effect, a muscle relaxing effect, a sedative effect, etc. In said formula, R represents oxo or -OR<1> (wherein R<1> represents hydrogen or acyl); A represents one of the following groups (2) and (3); Q represents hydrogen or lower alkyl; l is 1 or 2, m is 0 or 1; and n is 0, 1 or 2, provided that m and n are not 0 at the same time; R<2> represents optionally substituted benzoyl.
PT96916350T 1995-06-12 1996-06-07 BICYCLOLATING COMPOUNDS ITS USES AND INTERMEDIARIES IN ITS PRODUCTION PT790237E (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17032995 1995-06-12
JP27465495A JP3161948B2 (en) 1995-06-12 1995-09-27 Bicyclolactam compound

Publications (1)

Publication Number Publication Date
PT790237E true PT790237E (en) 2003-02-28

Family

ID=26493354

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96916350T PT790237E (en) 1995-06-12 1996-06-07 BICYCLOLATING COMPOUNDS ITS USES AND INTERMEDIARIES IN ITS PRODUCTION

Country Status (10)

Country Link
JP (1) JP3161948B2 (en)
KR (1) KR100220172B1 (en)
AT (1) ATE224369T1 (en)
AU (1) AU697656B2 (en)
CA (1) CA2197178C (en)
DE (1) DE69623747T2 (en)
DK (1) DK0790237T3 (en)
ES (1) ES2183956T3 (en)
PT (1) PT790237E (en)
WO (1) WO1996041796A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466933B1 (en) * 1990-02-02 1995-11-22 Taiho Pharmaceutical Company Limited Bicyclolactam derivative
PT713702E (en) * 1994-03-28 2005-01-31 Taiho Pharmaceutical Co Ltd ANSIOLITIC AGENT

Also Published As

Publication number Publication date
ES2183956T3 (en) 2003-04-01
KR100220172B1 (en) 1999-09-01
AU5911896A (en) 1997-01-09
JP3161948B2 (en) 2001-04-25
WO1996041796A1 (en) 1996-12-27
CA2197178C (en) 2001-05-01
KR970704686A (en) 1997-09-06
ATE224369T1 (en) 2002-10-15
CA2197178A1 (en) 1996-12-27
DE69623747D1 (en) 2002-10-24
JPH0959251A (en) 1997-03-04
AU697656B2 (en) 1998-10-15
DE69623747T2 (en) 2003-05-22
DK0790237T3 (en) 2002-10-14

Similar Documents

Publication Publication Date Title
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
AR038429A2 (en) MARCFORTINA 15-RENT-16-HYDROXYL COMPOUNDS
ES2056684T3 (en) CLEAR COSMETIC BARS WITH COMPATIBLE FRAGRANCE COMPONENTS.
ES2056153T3 (en) EXPECTORANT THAT INCLUDES A HYDROXIALKYLCHYSTEINE DERIVATIVE.
TR199801045T2 (en) Pesticides
AR003107A1 (en) DERIVATIVES OF VITAMIN D FOR DERMATOLOGICAL USE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THE PREPARATION OF SUCH DERIVATIVES.
ES2193248T3 (en) ANTRAQUINONAS MONO- AND DISULFOSUSTITUIDAS AND ITS USE FOR THE TREATMENT OF DISORDERS OF THE OSEA MATRIX.
IL111966A0 (en) 4-Benzoylisoxazole derivatives, their preparation and herbicidal compositions containing them
BR8004499A (en) COMPOSITIONS OF OPTICAL ACLARATORS AND THEIR APPLICATION
PT790237E (en) BICYCLOLATING COMPOUNDS ITS USES AND INTERMEDIARIES IN ITS PRODUCTION
TR199701298T1 (en) Tetralins.
ES2071458T3 (en) NEW AMIDIC COMPOUNDS OF 1- (ALCOXI-BENCIL) -PIPERACINES, THEIR PREPARATION PROCEDURES AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
EP0790237A4 (en) Bicyclolactam compounds, use of the same and intermediate in the production of the same
NZ229300A (en) Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions
AU3443593A (en) 4-oxo- and 4H-imidazo(5,1-C)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents
ATE277614T1 (en) ANXIOLYTIC ACTIVE INGREDIENTS
ES8605247A1 (en) Substituted arylsulfonyl guanidines.
BR9407232A (en) Thiocarbamoyl compounds
ES8703847A1 (en) Sulfonyl-guanidinopyrimidine derivatives.
ES2150034T3 (en) USE OF THE 2-AMINOTETRALINS SUBSTITUTED IN 6.7 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF SEPTIC SHOCK, AND ANTIPIRETIC AND ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS.
KR930703245A (en) Antiviral compounds
ES8703855A1 (en) Sulfonyl-guanidinotriazine derivatives.
EP0344982A3 (en) Alpha-adrenergic receptor antagonists
DK286090A (en) ALFA-ADRENERGE RECEPTOR ANTAGONISTS
MX9101421A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING NAPROXEN AND NAPROXEN SODIUM AND PSEUDOEFEDRINE HYDROCHLORIDE.